great lakes and oxychem complete 50-50 antimony oxide jv

1
Titanate catalysts from Alfa Aesar The broad range of titanium-based catalysts from Alfa Aesar can be used for esterification reactions of all types. Benefits include enhanced productivity, superior colour and purity, and reduced environmental impact. R&D quantities of standard products are available from stock; custom formulations are also available. Chemical and Engineering News, 10 May 2004, 82 (19) (Website: http://www.cen-online.org) Avantium Technologies, Degussa strengthen collaboration Degussa has widened its collaboration with Avantium Technologies by supplying a selection of its proprietary ligands and homogeneous catalysts to Avantium Technologies’ catalyst library. In 2001, Degussa had entered into a partnership when its portfolio of heterogeneous catalysts was incorporated into the catalyst library of Avantium Technologies. Avantium Technologies plans to use the homogenous catalysts in its high throughput experimentation and simulation technology for biopharma and chemical industries. Chemical Engineering World, Apr 2004, 39 (4), 32 Avecia licenses drug technology Avecia is to license several of its technologies to Japan’s Nard Institute, a contract research and process development company. The technologies include catalysts used in chiral production, some biocatalytic processes, and an encapsulated palladium catalyst used for cleaner drug development. Chemical and Engineering News, 17 May 2004, 82 (20), 15–16 (Website: http://www.cen-online.org) E.ON 2003: R&D For its fiscal 2003, the E.ON Group has reported R&D expenditure of 69 M (380 M for its fiscal 2002). The decline is mainly due to the deconsolidation of Degussa. Overall, 852 employees work in R&D at the E.ON group, of which: E.ON Energie 399, Ruhrgas 437, and Powergen 16. There is a detailed discussion of the group’s R&D activities. E.ON Annual Report 2003, 11 Dec 2003, 44 (E.ON AG, E.ON-Platz 1, 40479, Düsseldorf, Germany. Tel: +49 211 4579 367. Fax: +49 211 4579 532. Website: http://www.eon.com) Great Lakes and OxyChem complete 50-50 antimony oxide jv Great Lakes Chemical Corp has completed a transaction that will merge its antimony business with OxyChem’s Laurel Industries unit in a 50-50 jv called GLCC Laurel LLC. The new company will develop, produce, and market antimony-based flame retardants, synergists, and catalysts. Production will be consolidated into the existing Great Lakes’ antimony production plant in Reynosa, Mexico. Press release from Great Lakes Chemical Corp, 9025 North River Road, Suite 400, Indianapolis, IN 46240, USA. Tel: +1 317 715 3027. Website: http://www.greatlakes.com (27 Apr 2004) Iogen starts shipments of bioethanol The first commercial shipment of ethanol made from cellulosic biomass rather than grains has been made by Iogen. The company has a $45 M demonstration plant in Ottawa which processes 40 tonne/d wheat straw into ethanol. Enzymes for the process are manufactured in an adjacent plant. The global market for bio-fuels such as cellulose ethanol is expected to be at least $10 bn by 2012. Both Petro-Canada and Shell have interests in Iogen. Chemical Week, 12 May 2004, 166 (16), & Chemistry and Industry (London), 3 May 2004, (9), 4 (Website: http://www.chemind.org) Intercat buys hydrotalcite patents Sunoco Inc has sold US and foreign patent rights to its hydrotalcite catalysts, including manufacturing processes and use, to Intercat Inc. Chemical Market Reporter, 24 May 2004, (Website: http://www.chemicalmarketreporter.com) & European Chemical News, 31 May 2004, 80 (2102), 26 Fuel cells could power Johnson Matthey’s future Fuel cells, which turn hydrogen into power, are the technology of tomorrow, and Johnson Matthey, which makes parts for experimental fuel cells, is enjoying more revenues from its work than ever before. Losses in the division have been reduced by government funding and, in a few years’ time, this will be a significant contributor of value to the business. For now, though, JM is in a period of more pedestrian growth, with a weak dollar weighing further on prospects. Its main business for now is catalysts – chemicals used in things like emissions-reducing catalytic converters for cars – where figures yesterday were disappointing. Its main customers are Ford and Chrysler, who have been losing market share in the US. Global car production is improving, though, and in two years’ time there are tougher new rules on emissions from heavy duty diesel vehicles, which should drive demand. JM is also establishing a strong position as a supplier of ingredients to the pharmaceuticals manufacturers, particularly the growing producers of generic, or off- patent, drugs. A 15% rise in profits at this division to £42.3 M was the highlight of yesterday’s results, which showed a 3% rise in group pre-tax profits to £178 M for the year to 31 March. The sale of its colours and coatings business, for about £150 M, is due within the next few months. The shares fell 19p to 875.5p though are still worth tucking away. The Independent, 4 Jun 2004 Kemira sells Ecocat Kemira has sold the catalyst manufacturer Ecocat to the Finnish venture capital firm Eqvitec. Ecocat manufactures exhaust catalysts for the vehicle industry and has a turnover of around SKR 400 M. The carrier material in its products are metal rather than ceramics and these catalysts are more commonly used in diesel vehicles, motorbikes, and gardening equipment, which make up a growing market. The new ownership should give Ecocat a more effective global marketing system. Kemivarlden, May 2004, (5), 11 (in Swedish) & Press release from Kemira Oyj, Porkkalankatu 3, PO Box 330, FIN-00101 Helsinki, Finland. Tel: +358 (0)10 8611. Fax: +358 (0)10 862 1797. Website: http://www.kemira.com (3 May 2004) 4 JULY 2004 FOCUS ON CATALYSTS

Post on 05-Jul-2016

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Great Lakes and OxyChem complete 50-50 antimony oxide jv

Titanate catalysts from Alfa Aesar

The broad range of titanium-basedcatalysts from Alfa Aesar can be usedfor esterification reactions of all types.Benefits include enhancedproductivity, superior colour andpurity, and reduced environmentalimpact. R&D quantities of standardproducts are available from stock;custom formulations are alsoavailable.

Chemical and Engineering News, 10 May 2004, 82(19) (Website: http://www.cen-online.org)

Avantium Technologies, Degussastrengthen collaboration

Degussa has widened itscollaboration with AvantiumTechnologies by supplying a selectionof its proprietary ligands andhomogeneous catalysts to AvantiumTechnologies’ catalyst library. In 2001,Degussa had entered into apartnership when its portfolio ofheterogeneous catalysts wasincorporated into the catalyst library ofAvantium Technologies. AvantiumTechnologies plans to use thehomogenous catalysts in its highthroughput experimentation andsimulation technology for biopharmaand chemical industries.

Chemical Engineering World, Apr 2004, 39 (4), 32

Avecia licenses drug technology

Avecia is to license several of itstechnologies to Japan’s Nard Institute,a contract research and processdevelopment company. Thetechnologies include catalysts used inchiral production, some biocatalyticprocesses, and an encapsulatedpalladium catalyst used for cleanerdrug development.

Chemical and Engineering News, 17 May 2004, 82(20), 15–16 (Website: http://www.cen-online.org)

E.ON 2003: R&D

For its fiscal 2003, the E.ON Grouphas reported R&D expenditure of €69M (€380 M for its fiscal 2002). Thedecline is mainly due to thedeconsolidation of Degussa. Overall,852 employees work in R&D at theE.ON group, of which: E.ON Energie

399, Ruhrgas 437, and Powergen 16.There is a detailed discussion of thegroup’s R&D activities.

E.ON Annual Report 2003, 11 Dec 2003, 44 (E.ON AG,E.ON-Platz 1, 40479, Düsseldorf, Germany. Tel: +49211 4579 367. Fax: +49 211 4579 532. Website:http://www.eon.com)

Great Lakes and OxyChem complete50-50 antimony oxide jv

Great Lakes Chemical Corp hascompleted a transaction that willmerge its antimony business withOxyChem’s Laurel Industries unit in a 50-50 jv called GLCC Laurel LLC.The new company will develop,produce, and market antimony-basedflame retardants, synergists, andcatalysts. Production will beconsolidated into the existing GreatLakes’ antimony production plant inReynosa, Mexico.

Press release from Great Lakes Chemical Corp, 9025North River Road, Suite 400, Indianapolis, IN 46240,USA. Tel: +1 317 715 3027. Website:http://www.greatlakes.com (27 Apr 2004)

Iogen starts shipments of bioethanol

The first commercial shipment ofethanol made from cellulosic biomassrather than grains has been made byIogen. The company has a $45 Mdemonstration plant in Ottawa whichprocesses 40 tonne/d wheat strawinto ethanol. Enzymes for the processare manufactured in an adjacentplant. The global market for bio-fuelssuch as cellulose ethanol is expectedto be at least $10 bn by 2012. BothPetro-Canada and Shell haveinterests in Iogen.

Chemical Week, 12 May 2004, 166 (16), & Chemistryand Industry (London), 3 May 2004, (9), 4 (Website:http://www.chemind.org)

Intercat buys hydrotalcite patents

Sunoco Inc has sold US and foreignpatent rights to its hydrotalcitecatalysts, including manufacturingprocesses and use, to Intercat Inc.

Chemical Market Reporter, 24 May 2004, (Website:http://www.chemicalmarketreporter.com) & EuropeanChemical News, 31 May 2004, 80 (2102), 26

Fuel cells could power JohnsonMatthey’s future

Fuel cells, which turn hydrogen intopower, are the technology of

tomorrow, and Johnson Matthey,which makes parts for experimentalfuel cells, is enjoying more revenuesfrom its work than ever before. Lossesin the division have been reduced bygovernment funding and, in a fewyears’ time, this will be a significantcontributor of value to the business.For now, though, JM is in a period ofmore pedestrian growth, with a weakdollar weighing further on prospects.Its main business for now is catalysts– chemicals used in things likeemissions-reducing catalyticconverters for cars – where figuresyesterday were disappointing. Itsmain customers are Ford andChrysler, who have been losingmarket share in the US. Global carproduction is improving, though, andin two years’ time there are toughernew rules on emissions from heavyduty diesel vehicles, which shoulddrive demand. JM is also establishinga strong position as a supplier ofingredients to the pharmaceuticalsmanufacturers, particularly thegrowing producers of generic, or off-patent, drugs. A 15% rise in profits atthis division to £42.3 M was thehighlight of yesterday’s results, whichshowed a 3% rise in group pre-taxprofits to £178 M for the year to 31March. The sale of its colours andcoatings business, for about £150 M,is due within the next few months.The shares fell 19p to 875.5p though are still worth tucking away.

The Independent, 4 Jun 2004

Kemira sells Ecocat

Kemira has sold the catalystmanufacturer Ecocat to the Finnishventure capital firm Eqvitec. Ecocatmanufactures exhaust catalysts forthe vehicle industry and has aturnover of around SKR 400 M. Thecarrier material in its products aremetal rather than ceramics and thesecatalysts are more commonly used indiesel vehicles, motorbikes, andgardening equipment, which make up a growing market. The newownership should give Ecocat a more effective global marketingsystem.

Kemivarlden, May 2004, (5), 11 (in Swedish) & Pressrelease from Kemira Oyj, Porkkalankatu 3, PO Box330, FIN-00101 Helsinki, Finland. Tel: +358 (0)108611. Fax: +358 (0)10 862 1797. Website:http://www.kemira.com (3 May 2004)

4 JULY 2004

F O C U S O N C A T A L Y S T S